Should genetic testing become a standard component of clinical trials in order to advance evidence-based cardiology practice?
Medical therapy currently assumes that all individuals with a given condition should be treated in the same way, guided by empirical evidence from clinical trials. This ignores interindividual differences, which may predict variable therapeutic efficacy or adverse drug reactions. Considerable eviden...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2004
|